China pharma reliance deepens as Suez routes expand
The bottom line
Europe sources 67% of its active pharmaceutical ingredients from outside the region, with China and India controlling upstream supply, and that dependency is structural rather than temporary. Four more Gemini Asia-Europe services return to Suez westbound, improving schedule reliability but adding political risk. Freight costs on Gulf crude to China hit $162/mt, yet Beijing will not adjust fuel pricing, squeezing refiner margins.
Europe sources 67% of pharmaceutical APIs externally, China dominates upstream
The short version
Europe obtains 67% of active pharmaceutical ingredients from outside the region, with China and India controlling supply of APIs and key starting materials.
What happened
Europe relies on external sources for around 67% of the active pharmaceutical ingredients used in pharmaceutical production, while the US relies on an even larger proportion, according to Dr Vincent Van Bockstaele of the University of Antwerp speaking at the 2026 Pharma.Aero Masterclass in Frankfurt on 15 September. China has become the dominant supplier, with India representing another significant source.
India itself depends heavily on China for pharmaceutical inputs, meaning switching procurement from China to India does not eliminate the underlying Chinese dependency. China and India are expanding capabilities in finished pharmaceutical products, raising the prospect that Europe’s current upstream reliance on APIs could evolve into dependence on finished medicines.
Source: Air Cargo Week
Why it matters to you
If you ship pharmaceutical products or components, your supply chain sits on a foundation you do not control. The 67% figure reflects a deliberate strategy by European and US companies to offshore basic production while retaining high-value work at home, and China moved in the opposite direction, building vertical integration across manufacturing, technology, suppliers and logistics.
The India diversification story is a fiction for most buyers. When your Indian supplier sources key starting materials from China, you have added a step and a margin, not reduced your exposure. Multi-tier supply chain visibility is now a procurement requirement, because your Tier 1 supplier’s dependency is your dependency.
European chemical industry production fell significantly over the past decade, with investment down 80% in 2025. Pharmaceuticals could follow the same path if Chinese manufacturers move up the value chain into finished products. Your current API supplier could become your competitor in finished goods within five years.
The hot take
The pharmaceutical industry is having the supply chain conversation the electronics and automotive sectors had a decade ago, and it will end the same way. Companies that treat this as a sourcing problem rather than a structural problem will wake up in 2030 with fewer options and higher costs.
What to do about it
- Map your pharmaceutical supply chain to Tier 2 and identify which key starting materials come from China, even if your Tier 1 supplier is in India or Europe
- Price the cost of qualifying a second API supplier in a different geography and compare it to the revenue at risk if your primary source is disrupted for 90 days
- Ask your contract manufacturer for proof of API source diversification, not just a list of multiple suppliers who all buy from the same Chinese producer
Gemini adds four Asia-Europe services through Suez westbound, risk rises
The short version
Maersk and Hapag-Lloyd will send four more Asia-Europe services through Suez on westbound sailings, joining two already using the route.
What happened
Maersk and Hapag-Lloyd announced on 14 September that four more Asia-Europe services will return to Suez transits on westbound sailings. The Asia-North Europe AE5 string, the Asia-Mediterranean AE11 and AE12 services, and the India-Europe ME2 service will transit via Suez instead of sailing around the Cape of Good Hope.
The four services join the AE15 and AE19 Asia-Mediterranean services, which are already using the Suez routing. The decision comes despite an intensification of the war between Yemen’s Houthi militants and Saudi Arabia, which has elevated the risk of attack on vessels transiting the Red Sea.
Source: The Loadstar
Why it matters to you
Schedule reliability on Asia-Europe has been terrible for over a year, and this is the first meaningful structural fix from a major carrier pair. Westbound Suez transits will cut seven to ten days off the Cape route, which matters if you are trying to hit an FBA receiving window or a retail delivery date.
The catch is political risk. Sending ships through the Red Sea during an active conflict is a commercial decision that carriers can reverse with one week’s notice if a vessel is hit. You gain schedule reliability in the base case but add a new source of binary risk. If you have stock on the water on one of these six Suez services and the route closes, your container gets stuck on a ship that has to reroute mid-voyage.
Carriers are making this move because the customer pressure on schedule reliability outweighs the insurance cost and the risk of a Houthi strike. That calculus could change in a day. If you depend on Asia-Europe schedule performance for your Q4 inventory plan, do not assume the Suez routing is permanent.
The hot take
Carriers are choosing schedule reliability over safety because customers demanded it, and they are right to do so. But sellers who treat this as a return to normal are going to get caught when the first ship takes a missile and the entire route closes overnight.
What to do about it
- Check whether your booked Asia-Europe shipments are on AE5, AE11, AE12, ME2, AE15 or AE19 services and confirm the routing with your forwarder
- Add seven days of buffer to your Q4 FBA inbound plan for any Asia-Europe lanes, because the Suez routing could reverse with no notice
- Price air freight as a backup for any inventory that is margin-critical and currently booked on a Suez-routed service
Gulf to China crude freight hits $162/mt, Beijing caps domestic fuel price rises
The short version
Freight to ship Gulf crude to China reached $162/mt on 10 September, but China will not adjust its fuel pricing mechanism, squeezing refiner margins.
What happened
Dirty freight for a VLCC vessel to ship crude from the Gulf region to China was assessed at $162.16/mt on 10 September, up 4% from the previous day and exceeding the previous high of $124.14/mt on 4 March, according to Platts. Freight plus insurance premium currently amounts to around $30/barrel for shipping a VLCC cargo from the Gulf to China.
China is unlikely to adjust its oil product pricing mechanism despite the higher freight and insurance costs, according to two sources at think tanks speaking at the Asia Pacific Petroleum Conference on 8 to 10 September. On 11 September, the Chinese government limited domestic gasoline and gasoil price increases to 260 yuan/mt and 250 yuan/mt respectively, versus hikes of 435 yuan/mt and 420 yuan/mt indicated by the pricing mechanism.
Source: Hellenic Shipping News
Why it matters to you
If you ship heavy or bulky goods where domestic fuel costs are a material part of your factory’s input cost or your domestic haulage quote, this matters. Chinese refiners are absorbing freight cost increases that they cannot pass through to customers because the government caps retail price rises. That squeezes refiner margins, but it also means your factory’s diesel cost and your trucking rate are not spiking in line with global crude freight.
The pricing mechanism China uses adjusts retail ceiling prices for gasoline and gasoil every ten working days based on a basket of benchmark crude prices. Freight and insurance are minor, fixed elements in the formula. When freight costs triple, the mechanism does not reflect it. Domestic fuel users benefit, refiners lose.
This is not a permanent subsidy. If freight costs stay elevated for another six months, Beijing will face pressure to adjust the mechanism or let refiners reduce output. For now, your domestic transport cost in China is more stable than it should be given the global freight environment, and that is a policy choice rather than a market outcome.
The hot take
Beijing is subsidising domestic fuel users by forcing refiners to eat freight costs, and that is great for anyone moving goods inside China right now. But it is not sustainable. When refiners start losing serious money, the government will adjust the mechanism, and your trucking rate will spike.
What to do about it
- Review your ex-works pricing for any product where domestic haulage inside China is a significant cost component and confirm whether your factory has locked fuel costs for Q4
- If you run bonded warehouses in China, check whether your haulier has fixed rates through year-end or floating rates tied to diesel prices
- Do not assume current domestic transport rates in China are sustainable if crude freight stays above $150/mt into 2027
Chinese exporters’ global share forecast to hit 31% by 2035, from 18% now
The short version
Chinese companies’ average market share in export markets is projected to rise to 31% by 2035 from 18% in 2026, according to Goldman Sachs.
What happened
Chinese companies going global are projected to increase their average market share in export markets to 31% by 2035 from 18% in 2026, with revenue growing 3.6-fold over the period, according to a Goldman Sachs report published on 14 September. The report covered 40 global companies in 11 sectors, including 21 Chinese players and 19 of their global peers.
The biggest growth opportunities favour latecomers, including companies in sectors such as robotaxis, ecommerce, surgical robots, clear dental aligners and power equipment. Goldman Sachs analyst Trina Chen said markets have yet to price in China’s global growth opportunity, with a number of sectors trading at less than 1x earnings in international markets excluding China.
Source: South China Morning Post
Why it matters to you
If you source from China, your supplier base is not standing still. The factories you work with are looking at export markets and asking whether they should keep making your product or start selling their own. A 31% global export share by 2035 means Chinese companies will be taking share from someone, and that someone might be you.
The sectors Goldman Sachs highlights as having the most growth potential are exactly the ones where product differentiation is weak and manufacturing capability matters more than brand. If you sell power equipment, dental aligners or ecommerce-native products, your Chinese supplier has a clear path to becoming your competitor.
This is not a hypothetical risk. Anker did it in consumer electronics, Shein did it in fashion, and BYD is doing it in electric vehicles. The common thread is that they all started as suppliers or manufacturers and moved downstream into brand and distribution. If your product’s primary competitive advantage is that you understand the Western market and your supplier does not, that advantage has a half-life of about three years.
The hot take
The factory that makes your product is probably smarter than you are about manufacturing, and it is only a matter of time before it figures out that your margin is bigger than theirs. Build something your supplier cannot copy or accept that you are renting your market position.
What to do about it
- Identify which of your suppliers have launched their own branded products in any market, because that is your early warning system for when they come after yours
- Audit your product line and separate the items where you have real IP, formulation, or design protection from the ones where you are just the Western face on a Chinese factory’s output
- If you source commodity products and your only edge is logistics and customer access, price the cost of backward integrating into manufacturing or accept that your margin will compress every year
Content hooks
Angles from today’s stories, ready to turn into a post, a video or a note to your list. Take them. That is what they are for.
- 01 Europe sources 67% of pharmaceutical APIs externally, and switching from China to India does not reduce the risk because India buys from China
- 02 Your Indian API supplier’s Chinese dependency is your dependency, and adding a middleman is not diversification
- 03 Gemini is sending six Asia-Europe services through Suez westbound, which will cut seven to ten days off transit times but adds Red Sea conflict risk
- 04 Schedule reliability beats safety until the first ship gets hit, then the entire Suez routing closes overnight and your container is stuck
- 05 Gulf to China crude freight hit $162/mt but Beijing will not adjust domestic fuel prices, so refiners eat the cost and your factory’s diesel stays cheap
- 06 China’s fuel pricing mechanism is subsidising your domestic transport cost right now, but it is not sustainable if crude freight stays elevated into 2027
- 07 Chinese exporters will take 31% of global market share by 2035, up from 18% today, and they are coming for the sectors where manufacturing capability matters more than brand
- 08 The factory that makes your product is one Shopify store away from becoming your competitor, and the only question is when they figure out your margin is bigger than theirs
- 09 Pharmaceutical supply chains are repeating the same mistake the electronics and automotive industries made a decade ago, and it will end the same way
- 10 If your product’s only competitive advantage is that you understand the Western market and your supplier does not, that advantage has a three-year half-life
- 11 Carriers are choosing schedule reliability over Red Sea risk because customer pressure outweighs insurance costs, but that calculus changes the day a ship takes a missile
- 12 Beijing is forcing refiners to absorb $30/barrel freight costs to keep domestic fuel prices stable, which is great for you until refiners start cutting production
Questions people are asking
- Why does it matter that Europe sources 67% of pharmaceutical APIs externally?
- Europe and the US depend on China and India for most active pharmaceutical ingredients and key starting materials. This dependency is structural, not temporary. India itself relies heavily on China for inputs, so switching from Chinese to Indian suppliers does not eliminate exposure. China and India are expanding into finished medicines, so current upstream reliance could evolve into dependence on completed products. Building resilience requires multi-tier visibility and deliberate redundancy, not just finding the lowest-cost supplier.
- Are Asia-Europe container ships going through Suez again?
- Maersk and Hapag-Lloyd announced on 14 September that six Asia-Europe services will use Suez transits westbound instead of routing around the Cape. The services are AE5, AE11, AE12, ME2, AE15 and AE19. This cuts seven to ten days off transit times and improves schedule reliability. However, the Red Sea route is exposed to Houthi attacks during the Yemen-Saudi Arabia conflict. Carriers can reverse the decision with short notice if security deteriorates.
- Why are Chinese refiners losing money on fuel right now?
- Freight to ship Gulf crude to China hit $162.16/mt on 10 September, and freight plus insurance now totals around $30/barrel. Chinese refiners cannot pass these costs to customers because the government caps retail fuel price increases. On 11 September, Beijing limited gasoline price rises to 260 yuan/mt versus the 435 yuan/mt that the pricing formula indicated. The fuel pricing mechanism treats freight as a minor, fixed element. Refiners absorb the difference, keeping domestic fuel costs stable.
- Will my Chinese supplier become my competitor?
- Chinese companies’ average export market share is forecast to rise from 18% in 2026 to 31% by 2035, according to Goldman Sachs. Growth opportunities favour sectors where manufacturing capability matters more than brand, including ecommerce, power equipment and dental aligners. Suppliers that make your product have manufacturing cost, scale and logistics infrastructure. Many now have capital and are building brands. If your only advantage is market knowledge and customer relationships, that edge has a limited lifespan.
- Should I book Asia-Europe shipments through Suez or plan for Cape routing?
- Six Gemini services now transit Suez westbound, cutting seven to ten days off the Cape route. However, the Red Sea is exposed to conflict risk and carriers can reverse the decision quickly. If you book on a Suez service and the route closes, your container could get stuck on a ship that reroutes mid-voyage. Take the lead time benefit but add seven days of buffer to your Q4 plan. Do not assume the routing is permanent.
The bottom line
The bottom line
Europe sources 67% of its active pharmaceutical ingredients from outside the region, with China and India controlling upstream supply, and that dependency is structural rather than temporary. Four more Gemini Asia-Europe services return to Suez westbound, improving schedule reliability but adding political risk. Freight costs on Gulf crude to China hit $162/mt, yet Beijing will not adjust fuel pricing, squeezing refiner margins.